MCSP-BiTE

N/A

Report date: 2026/03/19 16:53:37

Base Information

Drug NameMCSP-BiTE
Drug Alias NameMelanoma-Associated Chondroitin Sulfate Proteoglycan/CD3 Bispecific Abs (Micromet)Anti-CD3/Anti-MCSP Bispecific T-Cell Engager (Micromet)MCSP-targeting BiTE antibodies (Micromet)MCSP-113MCSP-128 +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsImmunostimulantsChondroitin sulfate proteoglycans modulators +[4] 
TargetsT cell surface glycoprotein CD3Chondroitin sulfate proteoglycans
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Rockville Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmgen Rockville Inc
Active IndicationsN/A
Inactive IndicationsMelanomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A